Morré S A

Top coauthors of Morré S A

Ouburg S (18 papers)

Meijer C J (13 papers)

van den Brule A J (13 papers)

Peña A S (11 papers)

Lyons J M (9 papers)

List of Morré S A publications

2016

Alberts C J, Vos R A, Borgdorff H, Vermeulen W, van Bergen J, et al. 2016. "Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study." Sexually transmitted infections doi:10.1136/sextrans-2015-052397

2015

De Puysseleyr L, De Puysseleyr K, Braeckman L, Morré S A, Cox E, Vanrompay D 2015. "Assessment of Chlamydia suis Infection in Pig Farmers." Transboundary and emerging diseases doi:10.1111/tbed.12446
Verweij S P, Kebbi-Beghdadi C, Land J A, Ouburg S, Morré S A, Greub G 2015. "Waddlia chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology." Microbes and infection / Institut Pasteur 17 (11-12) doi:10.1016/j.micinf.2015.09.019

2014

Asner S A, Morré S A, Bochud P-Y, Greub G 2014. "Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20 (12) doi:10.1111/1469-0691.12806
van Aar F, de Moraes M, Morré S A, van Bergen J E A M, van der Klis F R M, et al. 2014. "Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age." Sexually transmitted infections 90 (5) doi:10.1136/sextrans-2013-051074

2013

Verweij S P, Quint K D, Bax C J, VAN Leeuwen A P, Mutsaers J A E M, et al. 2013. "Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands." Epidemiology and infection doi:10.1017/S095026881300071X
Lal J A, Malogajski J, Verweij S P, de Boer P, Ambrosino E, et al. 2013. "Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health." Public health genomics 16 (1-2) doi:10.1159/000346207
Schuurs T A, Verweij S P, Weel J F L, Ouburg S, Morré S A 2013. "Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in an STI population: performances of the Presto CT-NG assay, the Lightmix Kit 480 HT CT/NG and the COBAS Amplicor with urine specimens and urethral/cervicovaginal samples." BMJ open 3 (12) doi:10.1136/bmjopen-2013-003607

2011

Verweij S P, Catsburg A, Ouburg S, Lombardi A, Heijmans R, et al. 2011. "Lymphogranuloma venereum variant L2b-specific polymerase chain reaction: insertion used to close an epidemiological gap." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 17 (11) doi:10.1111/j.1469-0691.2011.03481.x
Bax C J, Quint K D, Peters R P H, Ouburg S, Oostvogel P M, et al. 2011. "Analyses of multiple-site and concurrent Chlamydia trachomatis serovar infections, and serovar tissue tropism for urogenital versus rectal specimens in male and female patients." Sexually transmitted infections 87 (6) doi:10.1136/sti.2010.048173
Sanders M S, van Well G T J, Ouburg S, Morré S A, van Furth A M 2011. "Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis." Genes and immunity 12 (5) doi:10.1038/gene.2011.20

2010

Barreiro-de Acosta M, Ouburg S, Morré S A, Crusius J B A, Lorenzo A, et al. 2010. "NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report." Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 102 (10) doi:
Land J A, Van Bergen J E A M, Morré S A, Postma M J 2010. "Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening." Human reproduction update 16 (2) doi:10.1093/humupd/dmp035

2009

Morré S A, Ouburg S, Peña A S, Brand A 2009. "The EU FP6 EpiGenChlamydia Consortium: contribution of molecular epidemiology and host-pathogen genomics to understanding Chlamydia trachomatis-related disease." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Lyons J M, Ouburg S, Morré S A 2009. "An integrated approach to Chlamydia trachomatis infection: the ICTI Consortium, an update." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Smelov V, Quint K D, Pleijster J, Savelkoul P H M, Shalepo K, et al. 2009. "Chlamydia trachomatis serovar distributions in Russian men and women: a comparison with Dutch serovar distributions." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Lyons J M, Igietseme J U, Black C M, Morré S A 2009. "Identification of candidate genes using the murine model of female genital tract infection with Chlamydia trachomatis." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Karimi O, Ouburg S, de Vries H J C, Peña A S, Pleijster J, et al. 2009. "TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
den Hartog J E, Lyons J M, Ouburg S, Fennema J S A, de Vries H J C, et al. 2009. "TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Ouburg S, Lyons J M, Land J A, den Hartog J E, Fennema J S A, et al. 2009. "TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Wang W, Stassen F R, Surcel H-M, Ohman H, Tiitinen A, et al. 2009. "Analyses of polymorphisms in the inflammasome-associated NLRP3 and miRNA-146A genes in the susceptibility to and tubal pathology of Chlamydia trachomatis infection." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Lyons J M, Morré S A, Land J A 2009. "Aspects of reproductive biology that influence the distribution and spread of Chlamydia trachomatis within the female genital tract: a new paradigm." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Verweij S P, Bax C J, Quint K D, Quint W G V, van Leeuwen A P, et al. 2009. "Significantly higher serologic responses of Chlamydia trachomatis B group serovars versus C and I serogroups." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:
Rabasseda X, Morré S A, Ouburg S 2009. "Bioinformatic approaches to the study of Chlamydial diseases." Drugs of today (Barcelona, Spain : 1998) 45 Suppl B doi:

2008

Kupreishvili K, ter Weeme M, Morré S A, van den Brule A J C, Huybregts M A J M, et al. 2008. "Increased infiltration of Chlamydophila pneumoniae in the vessel wall of human veins after perfusion." European journal of clinical investigation 38 (7) doi:10.1111/j.1365-2362.2008.01961.x
De Soet J J, van Gemert-Schriks M C M, Laine M L, van Amerongen W E, Morré S A, van Winkelhoff A J 2008. "Host and microbiological factors related to dental caries development." Caries research 42 (5) doi:10.1159/000151329

2007

Morré S A, Catsburg A, de Boer M, Spaargaren J, de Vries H J C, et al. 2007. "Monitoring the potential introduction of the Swedish Chlamydia trachomatis variant (swCT) in the Netherlands." Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 12 (10) doi:

2006

Gorter A C, Segura Z E, Savelkoul P H M, Morré S A 2006. "Chlamydia trachomatis infections in Nicaragua: preliminary results from a competitive voucher scheme to prevent and treat sexually transmitted infections and HIV/AIDS among sex workers." Drugs of today (Barcelona, Spain : 1998) 42 Suppl A doi:
Vanrompay D, Lyons J M, Morré S A 2006. "Animal models for the study of Chlamydia trachomatis infections in the female genital infection." Drugs of today (Barcelona, Spain : 1998) 42 Suppl A doi:
Morré S A, Spaargaren J, Ossewaarde J M, Land J A, Bax C J, et al. 2006. "Description of the ICTI consortium: an integrated approach to the study of Chlamydia trachomatis infection." Drugs of today (Barcelona, Spain : 1998) 42 Suppl A doi:
den Hartog J E, Morré S A, Land J A 2006. "Chlamydia trachomatis-associated tubal factor subfertility: Immunogenetic aspects and serological screening." Human reproduction update 12 (6) doi:10.1093/humupd/dml030

2005

Lammers K M, Ouburg S, Morré S A, Crusius J B A, Gionchett P, et al. 2005. "Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis." World journal of gastroenterology : WJG 11 (46) doi:
Laine M L, Morré S A, Murillo L S, van Winkelhoff A-J, Peña A S 2005. "CD14 and TLR4 gene polymorphisms in adult periodontitis." Journal of dental research 84 (11) doi:
Guo Q S, Xia B, Jiang Y, Morré S A, Cheng L, et al. 2005. "Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients." Postgraduate medical journal 81 (958) doi:10.1136/pgmj.2004.030825
Boeke A J P, van Bergen J E A M, Morré S A, van Everdingen J J E 2005. "[The risk of pelvic inflammatory disease associated with urogenital infection with Chlamydia trachomatis; literature review]." Nederlands tijdschrift voor geneeskunde 149 (16) doi:
Lyons J M, Ito J I, Peña A S, Morré S A 2005. "Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum." Journal of clinical pathology 58 (4) doi:10.1136/jcp.2004.021543
van der Paardt M, Crusius J B A, de Koning M H M T, Morré S A, van de Stadt R J, et al. 2005. "No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis." Annals of the rheumatic diseases 64 (2) doi:10.1136/ard.2004.021105

2004

Laine M L, Murillo L S, Morré S A, Winkel E G, Peña A S, van Winkelhoff A J 2004. "CARD15 gene mutations in periodontitis." Journal of clinical periodontology 31 (10) doi:10.1111/j.1600-051X.2004.00577.x
Lyons J M, Ito J I, Morré S A 2004. "Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of C trachomatis mediated pathogenesis." Journal of clinical pathology 57 (6) doi:

2003

Molano M, Weiderpass E, Posso H, Morré S A, Ronderos M, et al. 2003. "Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia." Sexually transmitted infections 79 (6) doi:

2001

van Valkengoed I G, Postma M J, Morré S A, van den Brule A J, Meijer C J, et al. 2001. "Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens." Sexually transmitted infections 77 (4) doi:
Pannekoek Y, van der Ende A, Eijk P P, van Marle J, de Witte M A, et al. 2001. "Normal IncA expression and fusogenicity of inclusions in Chlamydia trachomatis isolates with the incA I47T mutation." Infection and immunity 69 (7) doi:10.1128/IAI.69.7.4654-4656.2001

2000

van Valkengoed I G, Morré S A, van den Brule A J, Meijer C J, Devillé W, et al. 2000. "Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population." Sexually transmitted infections 76 (5) doi:
van Valkengoed I G, Boeke A J, Morré S A, van den Brule A J, Meijer C J, et al. 2000. "Disappointing performance of literature-derived selective screening criteria for asymptomatic Chlamydia trachomatis infection in an inner-city population." Sexually transmitted diseases 27 (9) doi:
Morré S A, Ossewaarde J M, Savelkoul P H, Stoof J, Meijer C J, van den Brule A J 2000. "Analysis of genetic heterogeneity in Chlamydia trachomatis clinical isolates of serovars D, E, and F by amplified fragment length polymorphism." Journal of clinical microbiology 38 (9) doi:
Morré S A, Stooker W, Lagrand W K, van den Brule A J, Niessen H W 2000. "Microorganisms in the aetiology of atherosclerosis." Journal of clinical pathology 53 (9) doi:
Morré S A, Rozendaal L, van Valkengoed I G, Boeke A J, van Voorst Vader P C, et al. 2000. "Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?" Journal of clinical microbiology 38 (6) doi:
Morré S A, Meijer C J, Munk C, Krüger-Kjaer S, Winther J F, et al. 2000. "Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: cost-saving strategy for epidemiological studies and screening programs." Journal of clinical microbiology 38 (4) doi:
van der Paardt M, van Denderen J C, van den Brule A J, Morré S A, van der Horst-Bruinsma I E, et al. 2000. "Prevalence of Chlamydia trachomatis in urine of male patients with ankylosing spondylitis is not increased." Annals of the rheumatic diseases 59 (4) doi:

1999

Morré S A, Van Valkengoed I G, Moes R M, Boeke A J, Meijer C J, Van den Brule A J 1999. "Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens." Journal of clinical microbiology 37 (10) doi:
Meijer A, Morré S A, van den Brule A J, Savelkoul P H, Ossewaarde J M 1999. "Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis." Journal of bacteriology 181 (15) doi:
Morré S A, van Valkengoed I G, de Jong A, Boeke A J, van Eijk J T, et al. 1999. "Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections." Journal of clinical microbiology 37 (4) doi:
van Valkengoed I G, Boeke A J, van den Brule A J, Morré S A, Dekker J H, et al. 1999. "[Systematic home screening for Chlamydia trachomatis infections of asymptomatic men and women in family practice by means of mail-in urine samples]." Nederlands tijdschrift voor geneeskunde 143 (13) doi:

1998

Morré S A, Moes R, Van Valkengoed I, Boeke J P, van Eijk J T, et al. 1998. "Genotyping of Chlamydia trachomatis in urine specimens will facilitate large epidemiological studies." Journal of clinical microbiology 36 (10) doi:
Morré S A, Sillekens P T, Jacobs M V, de Blok S, Ossewaarde J M, et al. 1998. "Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification." Molecular pathology : MP 51 (3) doi:
Morré S A, Ossewaarde J M, Lan J, van Doornum G J, Walboomers J M, et al. 1998. "Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis." Journal of clinical microbiology 36 (2) doi:

1996

Morré S A, Sillekens P, Jacobs M V, van Aarle P, de Blok S, et al. 1996. "RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples." Journal of clinical microbiology 34 (12) doi:

1995

van Nues R W, Rientjes J M, Morré S A, Mollee E, Planta R J, et al. 1995. "Evolutionarily conserved structural elements are critical for processing of Internal Transcribed Spacer 2 from Saccharomyces cerevisiae precursor ribosomal RNA." Journal of molecular biology 250 (1) doi:10.1006/jmbi.1995.0355